Category: Oncology
Advancements in EGFR-Mutant NSCLC Treatment Landscape
The treatment landscape for EGFR-mutant non-small cell lung cancer (NSCLC) has seen remarkable evolution with the emergence of targeted therapies. Here, we delve into the…
Advancements in Targeted Therapy for Lung Cancer
Targeted therapy has emerged as a significant advancement in the treatment of lung cancer, particularly for patients with specific genetic mutations or alterations in their…
Cancer Care in 2024 – Novel Therapies Delivering Greater Personalized Care!
In the ever-evolving landscape of cancer care in 2024, a host of innovative treatment modalities are revolutionizing our approach to this complex disease. Antibody Drug…
Lung Cancer Screening – Update
The American Cancer Society advises yearly screening for lung cancer with LDCT scans for individuals aged 50 to 80 who have a history of smoking….
Shaping the Future: Neoadjuvant Chemotherapy and Immunotherapy in NSCLC – Unveiling the Treatment Landscape
Neoadjuvant chemotherapy and immunotherapy have emerged as transformative approaches in the treatment of non-small cell lung cancer (NSCLC), reshaping the landscape of therapeutic strategies. By…
Fruquintinib Shows Promise in Heavily Pretreated Metastatic Colorectal Cancer Patients
Oral fruquintinib has shown improvement in overall survival in refractory metastatic colorectal cancer (mCRC). The phase 3 FRESCO-2 trial, studied patients with heavily pretreated mCRC…
Strength and Serenity: Navigating Cancer Treatment with Resilience
A cancer diagnosis can be one of life’s most challenging moments, impacting not only the body but also testing one’s mental and emotional resilience. The…
EV-302 Trial: Enfortumab Vedotin and Pembrolizumab Combo Ushers in a New Era for Bladder Cancer Treatment
The EV-302 trial, a groundbreaking phase 3 clinical study, has generated significant excitement in the field of urothelial cancer treatment. The trial assessed the efficacy…
Tumor Treating Fields (TTF): Pioneering Breakthrough Extends Survival in Non-Small Cell Lung Cancer – The Lunar Phase 3 trial
In a groundbreaking development, the Lunar Phase 3 trial has unveiled the remarkable efficacy of Tumor Treating Fields (TTFields) in non-small cell lung cancer (NSCLC)…
Neoadjuvant chemotherapy same as Upfront surgery in Overall Survival benefit – A phase 2 study of head of Pancreatic Cancer in resectable disease : NORPACT-1 Trial
The NORPACT-1 trial is a phase 2 clinical study that specifically enrolled patients with tumors located in the head of the pancreas. The trial focused…